Literature DB >> 6681035

Haemodynamic effects of nifedipine in essential hypertension at rest and during exercise.

P Lund-Johansen, P Omvik.   

Abstract

Fifteen males with previously untreated essential hypertension in WHO stage I, aged 20-64 years were studied on an outpatient basis. Oxygen consumption, heart rate, cardiac in a in a supine and sitting position and during steady state work at 50, 100 and 150 W. Following the haemodynamic study, nifedipine (long-acting form) 40-80 mg daily was given as the sole drug for 3-12 months (mean 11 months) whereupon the haemodynamic study was repeated. Systolic, diastolic and mean arterial pressures fell about 17% at rest supine and sitting and from 15 to 10% at the three different workloads (P less than 0.001). All but one patient demonstrated a fall in mean arterial pressure of 10 mmHg or more. The fall in pressure was associated with a statistically significant (P less than 0.05) reduction in total peripheral resistance (17% during rest and 10 to 16% during exercise). There were no statistically significant changes in oxygen consumption, heart rate, cardiac index or stroke index.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6681035     DOI: 10.1097/00004872-198308000-00008

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

1.  Acute haemodynamic effects of urapidil and nifedipine in hypertensive urgencies and emergencies.

Authors:  F Späh; K D Grosser; G Thieme
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

3.  Acute effects of felodipine and nifedipine on hepatic and forearm blood flow in healthy men.

Authors:  B Bengtsson-Hasselgren; O Rönn; L O Blychert; B Edgar; S Raner
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Acute and long-term hemodynamic effects of tiapamil at rest and during exercise in essential hypertension.

Authors:  P Omvik; P Lund-Johansen
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

5.  The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.

Authors:  V Challenor; D G Waller; B S Gruchy; A G Renwick; C F George; E T McMurdo; J McEwen
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

6.  The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension.

Authors:  P L Katzman; U L Hulthén; B Hökfelt
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

7.  Effects of ACE inhibition on endurance exercise haemodynamics in trained subjects with mild hypertension.

Authors:  P Palatini; S Bongiovi; L Mario; P Mormino; G Raule; A C Pessina
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.

Authors:  P Lund-Johansen; P Omvik; H Haugland
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 9.  Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.

Authors:  P Lund-Johansen
Journal:  Drugs       Date:  1984       Impact factor: 9.546

Review 10.  Calcium antagonists and exercise performance.

Authors:  W Kindermann
Journal:  Sports Med       Date:  1987 May-Jun       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.